Malak Alannan

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 11

Top Topics

Raman Spectroscopy

Cardiovascular Disease

Low Density Lipoprotein

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Malak Alannan, Hala Fatrouni, Véronique Trézéguet, Franziska Dittrich-Domergue, Patrick Moreau, Géraldine Siegfried, Benjamin Liet, Abdel-Majid Khatib, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis. Cells 12 (1) (2022)
Malak Alannan, Véronique Trézéguet, Nivea Dias Amoêdo, Rodrigue Rossignol, Walid Mahfouf, Hamid Reza Rezvani, Franziska Dittrich-Domergue, Patrick Moreau, Sabrina Lacomme, Etienne Gontier, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers 15 (1) (2022)
Malak Alannan, Véronique Trézéguet, Nivea Dias Amoêdo, Rodrigue Rossignol, Walid Mahfouf, Hamid Reza Rezvani, Franziska Dittrich-Domergue, Patrick Moreau, Sabrina Lacomme, Etienne Gontier, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers 15 (1) (2022)
Malak Alannan, Hala Fatrouni, Véronique Trézéguet, Franziska Dittrich-Domergue, Patrick Moreau, Géraldine Siegfried, Benjamin Liet, Abdel-Majid Khatib, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis. Cells 12 (1) (2022)
Malak Alannan, Nabil G Seidah, Aksam J Merched
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 11 (24) (2022)
Malak Alannan, Hala Fatrouni, Véronique Trézéguet, Franziska Dittrich-Domergue, Patrick Moreau, Géraldine Siegfried, Benjamin Liet, Abdel-Majid Khatib, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis. Cells 12 (1) (2022)
Malak Alannan, Nabil G Seidah, Aksam J Merched
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 11 (24) (2022)
Malak Alannan, Nabil G Seidah, Aksam J Merched
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 11 (24) (2022)
Malak Alannan, Hala Fatrouni, Véronique Trézéguet, Franziska Dittrich-Domergue, Patrick Moreau, Géraldine Siegfried, Benjamin Liet, Abdel-Majid Khatib, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis. Cells 12 (1) (2022)
Malak Alannan, Véronique Trézéguet, Nivea Dias Amoêdo, Rodrigue Rossignol, Walid Mahfouf, Hamid Reza Rezvani, Franziska Dittrich-Domergue, Patrick Moreau, Sabrina Lacomme, Etienne Gontier, Christophe F Grosset, Bassam Badran, Hussein Fayyad-Kazan, Aksam J Merched
Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers 15 (1) (2022)
Malak Alannan, Nabil G Seidah, Aksam J Merched
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 11 (24) (2022)